SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-000516
Filing Date
2024-01-03
Accepted
2024-01-03 18:12:19
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7514
  Complete submission text file 0001209191-24-000516.txt   8967
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Issuer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037
Business Address
Zedelmayer Christine (Reporting) CIK: 0001797818 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38692 | Film No.: 24508733